透過您的圖書館登入
IP:3.145.16.90

並列摘要


A growing body of evidence suggests the potential role of chymase in organ injury in diabetes. We investigated blood glucose levels and survival in transgenic mice carrying the human chymase gene (Tg). Intraperitoneal injections of streptozotocin (STZ) (200, 100, 75 and 50 mg/kg in total, i.p.) were given to uninephrectomized Tg mice and wild-type C57BL/6 (BL) mice. Before STZ injection, the Tg mice had significantly lower body weights and slightly higher systolic blood pressure as compared with the BL mice. STZ-treated Tg mice showed significantly higher postprandial blood glucose levels as compared with the STZ-treated BL mice. The survival prevalence of STZ-treated Tg mice was zero, whereas BL mice showed a value of 40% until 42 days. STZ (100, 75 or 50 mg/kg, i.p.)-treated Tg mice also showed a similar pattern as compared with the STZ-treated BL mice. These data suggest that human chymase contributes to blood glucose levels and mortality during the progression of diabetes.

參考文獻


Cristovam, P.C.,Arnoni, C.P.,de Andrade, M.C.,Casarini, D.E.,Pereira, L.G.,Schor, N.,Boim, M.A.(2008).ACE-dependent and chymase-dependent angiotensin II generation in normal and glucose- stimulated human mesangial cells.Exp. Biol. Med. (Maywood).233,1035-1043.
Dell''Italia, L.J.,Husain, A.(2002).Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases.Curr. Opin. Cardiol..17,374-379.
He, S.,Peng, Q.,Walls, A.F.(1997).Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine.J. Immunol..159,6216-6225.
Hoffmann, S.,Krause, T.,van Geel, P.P.,Willenbrock, R.,Pagel, I.,Pinto, Y.M.,Buikema, H.,van Gilst, W.H.,Lindschau, C.,Paul, M.,Inagami, T.,Ganten, D.,Urata, H.(2001).Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy.J. Mol. Med..79,601-608.
Huang, X.R.,Chen, W.Y.,Truong, L.D.,Lan, H.Y.(2003).Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease.J. Am. Soc. Nephrol..14,1738-1747.

延伸閱讀